Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,11S,17S,23S,32S,38S,44S)-11,32-bis(4-acetamidobutyl)-44-amino-23-(4-aminobutyl)-38-(3-guanidinopropyl)-45-hydroxy-17-isobutyl-2-methyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaazapentatetracontan-1-oic acid
ID: ALA4748520
Chembl Id: CHEMBL4748520
PubChem CID: 162649993
Max Phase: Preclinical
Molecular Formula: C56H99N21O19
Molecular Weight: 1370.54
Molecule Type: Unknown
Associated Items: